SignalIQ Stock Brief™
Published · as of 2026-07-24
The most pronounced structural change observed is the sharp decrease in momentum over the past seven days (-31.0), indicating a significant loss of short-term buying pressure or trend adherence. Despite this, the high quality score (82.0) suggests that the company's underlying business fundamentals and operational health remain robust. The current timing score (35.0) is notably low, suggesting that market entry points may be suboptimal relative to historical averages. This combination of high intrinsic quality paired with poor immediate momentum and weak timing signals creates a structural tension: the asset possesses strong foundational characteristics but lacks immediate directional catalyst or optimal entry conditions. Risk remains elevated at 47.0, which aligns with the negative trend direction (-1.0) observed in the score vector. The signal metrics confirm this caution, showing an alpha of -23.23 and a negative Sharpe ratio of -0.35, reinforcing that recent returns have been poor relative to risk taken. A potential watch item is required: Monitor if the momentum delta reverses (delta > 10.0) while the quality score remains above 80.0; this would signal a confluence of renewed short-term interest and sustained fundamental strength.
Summary ▸
The significant decline in momentum (delta -31.0) suggests a rapid shift in short-term price action, while the quality score remains elevated at 82.0. This divergence implies that underlying fundamental strength is intact despite recent weakness in market timing and directional conviction.
In a Neutral regime, DXCM's AIQ Score of 54/100 with Quality base of 82/100 and fading Momentum at 45/100 (Δ-31) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.
Valuation (37/100) is diverging from Momentum (45/100) and Sentiment (91/100) and Quality (82/100). DXCM's strong momentum and positive signals are running ahead of fundamental value — a setup that has historically required monitoring for mean reversion. Watch for RSI overbought signals as a confirmation trigger.
Quick Stats
DXCM's 7-day signal profile is softening with AIQ change of -8.0 points and momentum delta of -31.0. Trend delta is -8.00, which helps frame whether the current move is accelerating or fading.
Snapshot: Sun, 26 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.
| Date | AIQ | Mom | Val | Qual | Resilience |
|---|---|---|---|---|---|
| 2026-07-25 | 54 | 45 | 37 | 82 | 47 |
| 2026-07-18 | 62 | 76 | 37 | 82 | 47 |
| 2026-07-11 | 61 | 68 | 37 | 82 | 53 |
| 2026-07-04 | 56 | 51 | 37 | 82 | 49 |
| 2026-06-27 | 56 | 53 | 37 | 82 | 50 |
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AI Analysis Report
Scenario Analysis
AIQ Scenario Builder
DXCM (DXCM) Stock Analysis
DXCM (DXCM) has an AIQ Score of 54/100 in a Neutral regime as of Jul 25, 2026. Sentiment is strongest at 91/100. Value is weakest at 37/100. The main conflict is that quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts).
DXCM (DXCM) carries an AIQ Score of 54 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.
Beta is 1.53, implying roughly 53% higher sensitivity than a broad market baseline.
In the latest weekly profile, AIQ has moved -8.0 points over the last 7 days, momentum delta is -31.0, trend delta is -8.00, risk delta is 0.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | DXCM is in a Neutral AIQ regime with score 54/100. |
| Signal Conflict | The primary conflict is that quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts). |
| Factor Evidence | Momentum 45/100 · Value 37/100 · Quality 82/100 · Risk 47/100 · Sentiment 91/100 |
| Persistence | DXCM has scored AIQ 60+ in 30 of the last 60 daily snapshots. 30-day avg: 58/100. 60-day avg: 59/100. |
| Checklist | Status | Evidence |
|---|---|---|
| Factor strength | Pass | Sentiment is the strongest factor at 91/100. |
| Timing | Wait | Momentum is 45/100 with 7-day delta -31.0. |
| Regime fit | Wait | DXCM is in a Neutral regime at 54/100. |
| Risk control | Wait | Risk factor is 47/100 with beta of 1.53 indicates above-market sensitivity. |
| Conflict | Wait | Current conflict: quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts). |
DXCM's 7-day signal profile is softening with AIQ change of -8.0 points and momentum delta of -31.0. Trend delta is -8.00, which helps frame whether the current move is accelerating or fading.
Signal snapshot as of Sun, 26 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.
| Metric | Current |
|---|---|
| AIQ Score | 54/100 |
| Price | $71.54 |
| Beta | 1.53 |
DXCM vs Medical Devices Peers
Portfolio Implication
Related Links
DXCM Stock FAQ
What does the DXCM AIQ Score mean?
AIQ Score summarizes multiple factors for DXCM, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.
How often is DXCM data updated?
DXCM quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.
Should I compare DXCM with an index before investing?
Yes. Comparing DXCM versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.
Where can I review deeper DXCM fundamentals, technicals, and risk?
Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.
How the AIQ Score Is Built
Methodology, factor weights, and how to interpret score history
Loading DXCM...